STipe Therapeutics appoints Dr Richard Sainson as Chief Scientific Officer to Lead Research and Discovery
He will be based in Aarhus, Denmark and report to Dr Claus Olesen, STipes Chief Executive Officer (CEO).
- He will be based in Aarhus, Denmark and report to Dr Claus Olesen, STipes Chief Executive Officer (CEO).
- As CSO, Dr Sainson will lead the research and advancement of the Companys innovative science and platform technology.
- I look forward to applying my experience and expertise to harness these strengths and to addressing the unmet needs of patients.
- Richard Sainson has over 20 years of oncology research experience acquired both in academia and industry.